Mongolian medicine for curing lung interstitial substance fibrosis
A technology of pulmonary interstitial fibrosis and Mongolian medicine, which is applied in the field of medicine, can solve the problems of complicated treatment, unreported drugs with definite curative effect, and limited therapeutic effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment Construction
[0008] Select raw materials according to the standard: 60g of wintergreen leaves, 40g of salvia miltiorrhiza, 40g of northern sea ginseng, 20g of seabuckthorn, 20g of bitter almond, 20g of licorice, and 10g of geranium. After crushing, pass through a 200-mesh sieve, and pack into capsules.
[0009] Dosage: 3-5g / time, 2-3 times / day.
[0010] Prescription principles and pharmacological analysis: The pathological damage of interstitial pneumonia is mainly inflammation of the alveolar wall in the early stage of the disease, diffuse pulmonary interstitial fibrosis in the middle stage, and fibrosis of the alveolar wall in the late stage. X-ray lung examination, especially high-resolution CT (HRCT) examination, can be found in both lung lobes, especially the lower lung lobe, showing dense and fine reticular nodules, which are relatively uniform and ill-defined, or There are cord-like lesions, grid shadows, and honeycombing. The biggest feature of this disease is: insidious onset, p...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com